Breast Cancer Risk Assessment and Treatment

Article

Personalized medicine is here. It's the responsibility of OB/GYNs, other women's health care clinicians, and primary care providers to understand how it can impact the decisions we and our patients make.

Read two case studies demonstrating the many ways in which genetic testing, breast cancer prognostic tests, and personalized medicine have improved the very foundation of patient care in this area.

Watch the associated video, below!

Learn How SNPs May Assist in Assessing Breast Cancer Risks for Your Patients

  

 

Recent Videos
Improving pediatric HPV vaccination rates: Early initiation and addressing disparities | Image Credit: blog.nemours.org.
New cervical cancer screening guidelines: What practitioners needs to know | Image Credit: forhers.com
COVID-19 Therapy Roundtable: Focusing on inpatient care
COVID-19 Therapy Roundtable: Defining the virus today and treatment options
How fezolinetant advances non-hormonal treatment of hot flashes | Image Credit: medschool.cuanschutz.edu
Contraceptive access challenges for college students in contraception deserts | Image Credit: linkedin.com.
Kameelah Phillips, MD, FACOG, NCMP, is featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.